Emergent Biosolutions EBS Income Statements

Conto economico

Quarter End	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	242,7M	240M	330,7M	165,1M	337,9M	269,7M	276,6M	300,4M
Reddito operativo	-72M	-42M	-65,1M	-148,1M	13,8M	-548,3M	-73,7M	39,8M
Reddito ante imposte	-82,8M	-63,9M	-71,2M	-161,1M	-250,2M	-265,4M	-54,5M	12,1M
Reddito netto	-56,4M	-75,7M	-88M	-183M	-261,3M	-266,7M	-49,5M	9M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-75M	-55,4M	-58,4M	-143,2M	85,1M	-476,2M	9,4M	36,4M
EBITDA	-41,5M	-9,9M	-22,6M	-113,5M	46,7M	4,6M	-44,1M	67,7M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	488,78M	560,87M	782,4M	1,11B	1,56B	1,79B	1,12B	1,05B
Reddito operativo	104,12M	124,29M	89,8M	114,1M	433,8M	352,6M	-172,7M	-726,4M
Reddito ante imposte	97,82M	118,63M	81,5M	77,4M	407,2M	314,4M	-221,7M	-731,2M
Reddito netto	50,38M	82,59M	62,7M	54,5M	305,1M	230,9M	-223,8M	-760,5M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0.8	1.15	0.852	0.736	4.042	3.133	-3.087	-10.239
UTILE OPERATIVO	104,38M	123,47M	91,4M	115,8M	438,5M	348,9M	-184,4M	-643,3M
EBITDA	139,72M	165,06M	151,1M	234,3M	572,7M	515M	-22,7M	-76,4M